ArticleNeuro-oncology2026

SMARCAL1 is a targetable synthetic lethal therapeutic vulnerability in ATRX-deficient gliomas that use alternative lengthening of telomeres.

Alexandrea Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.